Nisa Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB
Nisa Investment Advisors's HZNP Position: Q4 2023 in Review
Nisa Investment Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 122,131 shares — an estimated $14.1M sold.
Nisa Investment Advisors first reported a position in HZNP in Q4 2016 and held it in 25 quarters. The position peaked at $14.1M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Nisa Investment Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Nisa Investment Advisors sold 122,131 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $14.1M.
- Nisa Investment Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 25 quarters.
- Nisa Investment Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $14.1M in Q3 2023.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on Nisa Investment Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.